Stocktoria
TriSalus Life Sciences, Inc. TLSI
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2020-12-18
Chart by TradingView
4/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $45.2M | $29.4M | $18.5M | $12.4M | — |
| Gross profit | $38.2M | $25.3M | $15.9M | $10.1M | — |
| Operating income | -$26.9M | -$36.2M | -$54.5M | -$36.4M | -$3.0M |
| Net income | -$39.2M | -$30.0M | -$59.4M | -$47.2M | $4.8M |
| Operating cash flow | -$18.0M | -$40.8M | -$50.6M | -$32.3M | -$1.7M |
| Free cash flow | -$18.9M | -$41.2M | -$51.2M | -$33.0M | — |
| Total assets | $35.3M | $24.0M | $24.6M | $22.0M | $250.5M |
| Total liabilities | $69.2M | $49.9M | $51.7M | $34.3M | $17.3M |
| Shareholders' equity | -$33.9M | -$25.9M | -$27.1M | -$177.1M | -$129.6M |
| Ratios | |||||
| Gross margin | 84.6% | 86.1% | 85.9% | 81.8% | — |
| Operating margin | -59.7% | -122.9% | -294.3% | -293.9% | — |
| Net margin | -86.9% | -102.1% | -320.7% | -380.6% | — |
| FCF margin | -41.9% | -139.9% | -276.4% | -265.9% | — |
| Return on assets | -111.0% | -125.3% | -241.3% | -214.5% | 1.9% |
| Return on equity | 115.8% | 116.0% | 219.3% | 26.6% | -3.7% |
| Debt / equity | -0.98× | -0.85× | -0.00× | — | — |
| Current ratio | 2.80 | 2.02 | 1.42 | 0.53 | 0.33 |
| Revenue growth | 53.4% | 59.0% | 49.3% | — | — |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 30,900 | $123,600 |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001826667 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.